# Phase IIb Study of STA-2 in Patients With Chronic Stable Angina

Study · id `cardio:ct-nct01239511` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01239511](<https://clinicaltrials.gov/study/NCT01239511>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01239511

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 186 participants.

## Technical summary

Registry record NCT01239511. Randomized; double masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2012-04 (actual). Results posted on 2014-08-27.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 186 participants (enrolled count; ClinicalTrials.gov record NCT01239511, source copy `cardio:ctgov-nct01239511-2014-08-27`, retrieved 2026-10-31)
- Start date: 2010-11 (registry gives no type) (ClinicalTrials.gov record NCT01239511, source copy `cardio:ctgov-nct01239511-2014-08-27`, retrieved 2026-10-31)
- Primary completion: 2012-04 (actual) (ClinicalTrials.gov record NCT01239511, source copy `cardio:ctgov-nct01239511-2014-08-27`, retrieved 2026-10-31)
- Completion: 2012-04 (actual) (ClinicalTrials.gov record NCT01239511, source copy `cardio:ctgov-nct01239511-2014-08-27`, retrieved 2026-10-31)
- Results first posted: 2014-08-27 (ClinicalTrials.gov record NCT01239511, source copy `cardio:ctgov-nct01239511-2014-08-27`, retrieved 2026-10-31)
- Countries: Taiwan (ClinicalTrials.gov record NCT01239511, source copy `cardio:ctgov-nct01239511-2014-08-27`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01239511-2014-08-27`, retrieved 2026-10-31)

## The registry's words

- Brief title: Phase IIb Study of STA-2 in Patients With Chronic Stable Angina
- Condition: Chronic Stable Angina
- Intervention (Drug): green tea polyphenols (STA-2)
- Lead sponsor: Sinphar Pharmaceutical Co., Ltd
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)

## Provenance

Content hash: 6172d18f3661a67b21cd0cf3833ce36d759c185cc4a93f52376d7acf4e685594
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
